Companies: 10,795·Total market cap: $144.5T
Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions Class A Ordinary Shares

MNDRNASDAQHealthcare● Active
$0.71
$-0.00(-0.01%)
Market Cap$630747
P/E Ratio
52W High$7.95
52W Low$0.656

Mobile-health Network Solutions Class A Ordinary Shares (MNDR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

mndr · pe ratio · data through Jun 30, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Mobile-health Network Solutions Class A Ordinary Shares (MNDR) measures how much investors pay for each dollar of the company's trailing earnings. MNDR's current PE ratio of N/A is calculated by dividing its stock price of $0.71 by its TTM earnings per share of -$1.17.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30

Forward P/E
0.89x
FY2026 est. EPS $0.80
Based on 1 analyst
EPS (TTM)
-$1.17
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Mobile-health Network Solutions Class A Ordinary Shares SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2021 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 3342.0x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Care Facilities · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions Class A Ordinary SharesYou
MNDR
$1MN/A-$1.17
Ainos, Inc.
Ainos, Inc.
AIMD
$9MN/A-$3.46
Artelo Biosciences, Inc.
Artelo Biosciences, Inc.
ARTL
$3MN/A-$5.47
bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc.
BIAF
$7MN/A-$8.66
Carisma Therapeutics, Inc.
Carisma Therapeutics, Inc.
CARM
$0MN/A-$1.46
GT Biopharma, Inc.
GT Biopharma, Inc.
GTBP
$4MN/A-$5.14
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc.
LIPO
$0MN/A-$4.79

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-06-30Latest
FY2025
$-14.42
2024-06-30
FY2024
$-22.44
2023-06-30
FY2023
$-2.77
2022-06-30
FY2022
3341.99x$0.08
2021-06-30
FY2021
$-0.54

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Mobile-health Network Solutions Class A Ordinary Shares (MNDR) measures how much investors pay for each dollar of the company's trailing earnings. MNDR's current PE ratio of N/A is calculated by dividing its stock price of $0.71 by its TTM earnings per share of -$1.17.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.71 ÷ -$1.17 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

MNDR pe ratio · 6 questions

MNDR's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.71 and TTM EPS of -$1.17. Data sourced from Financial Modeling Prep via MNDR's SEC 10-K and 10-Q filings.

MNDR PE ratioWhat is MNDR PE ratioCurrent PE ratio of MNDRMNDR PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Mobile-health Network Solutions Class A Ordinary Shares SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09